A phase II study for metabolic in vivo response monitoring with sequential 18FDG-PET-CT during treatment with the EGFR-monoclonal-antibody cetuximab in metastatic colorectal cancer: the Heidelberg…

Overview of attention for article published in BMC Cancer, March 2012

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (52nd percentile)

Mentioned by

twitter: 1 X user

peer_reviews: 1 peer review site

Citations

dimensions_citation: 5 Dimensions

Readers on

mendeley: 38 Mendeley

Summary X Peer reviews Dimensions citations

So far, Altmetric has seen 1 peer review site that discusses this research output.

PubPeer

This paper has 1 comment on PubPeer, an open scientific commentary website.

Comment from PubMed Commons

30 Aug 2016

Ben Goldacre | Aug 30 2016 12:33 ESTThis trial has the wrong trial registry ID associated with it on PubMed: both in the XML on PubMed, and in the originating journal article...

This page shows the most recent peer reviews that mention this research output.

Click here to find out how to access more activity.